GeneHealth - Your precision medicine

Subclavian Steal Syndrome

Disease Details

Family Health Simplified

Buy Membership

Description: Subclavian steal syndrome is characterized by the reversal of blood flow in the vertebral artery due to a significant stenosis or occlusion in the subclavian artery, leading to reduced blood flow to the brain and symptoms such as dizziness, vertigo, and syncope.
Type: Subclavian steal syndrome is not typically associated with genetic transmission. It is a vascular condition that occurs when there is a significant stenosis or occlusion of the subclavian artery proximal to the origin of the vertebral artery, causing retrograde blood flow in the vertebral artery to supply the affected arm.
Signs And Symptoms: Presyncope (sensation that one is about to faint)
Syncope (fainting)
Neurologic deficits
Blood pressure differential between the arms
severe memory problems
hands showing circulation problems (hands can have blotchy patches of red and white) (associated with other stigmata of vascular disease (e.g. vascular insufficiency ulcers of the fingers).
Prognosis: Subclavian steal syndrome typically has a good prognosis when properly diagnosed and treated. The condition itself is generally not life-threatening, but treatment is essential to manage symptoms and prevent complications. Treatment options include lifestyle changes, medications, and potentially surgical interventions such as angioplasty or bypass surgery to restore proper blood flow. Regular monitoring and follow-up care are important for maintaining long-term health.
Onset: Subclavian Steal Syndrome typically has a gradual onset. The underlying cause is usually atherosclerosis, which progresses over time, leading to compromised blood flow. The symptoms can develop slowly as the condition worsens.
Prevalence: Subclavian steal syndrome is relatively uncommon, though the exact prevalence is not well-documented. It can occur more frequently in older adults and those with extensive atherosclerosis or other cardiovascular risk factors.
Epidemiology: Subclavian steal syndrome (SSS) is relatively rare, typically affecting individuals over the age of 55, with a higher prevalence in males. The exact incidence and prevalence are not well-documented due to its often asymptomatic nature. However, it is estimated to occur in approximately 0.6% to 4% of the general population. The syndrome is more common in individuals with a history of atherosclerotic disease, such as those with coronary artery disease, peripheral artery disease, or a history of smoking.
Intractability: Subclavian steal syndrome is not generally considered intractable. It can often be managed effectively with lifestyle changes, medications, or surgical interventions, depending on the severity and underlying cause of the condition. Treatment options such as angioplasty or bypass surgery can restore adequate blood flow and alleviate symptoms in many cases.
Disease Severity: Subclavian steal syndrome is generally not considered to be life-threatening in itself, but the symptoms can range from mild to severe. The severity often depends on the degree of arterial blockage and the presence of other cardiovascular conditions. Mild cases may only cause occasional symptoms like dizziness or arm weakness, while more severe cases could lead to significant neurological deficits or complications due to inadequate blood flow. Early diagnosis and management are important to prevent worsening of the condition.
Healthcare Professionals: Disease Ontology ID - DOID:13002
Pathophysiology: Classically, SSS is a consequence of a redundancy in the circulation of the brain and the flow of blood.
SSS results when the short low resistance path (along the subclavian artery) becomes a high resistance path (due to narrowing) and blood flows around the narrowing via the arteries that supply the brain (left and right vertebral artery, left and right internal carotid artery). The blood flow from the brain to the upper limb in SSS is considered to be stolen as it is blood flow the brain must do without. This is because of collateral vessels.As in vertebral-subclavian steal, coronary-subclavian steal may occur in patients who have received a coronary artery bypass graft using the internal thoracic artery (ITA), also known as internal mammary artery. As a result of this procedure, the distal end of the ITA is diverted to one of the coronary arteries (typically the LAD), facilitating blood supply to the heart. In the setting of increased resistance in the proximal subclavian artery, blood may flow backward away from the heart along the ITA, causing myocardial ischemia due to coronary steal. Vertebral-subclavian and coronary-subclavian steal can occur concurrently in patients with an ITA CABG.
Carrier Status: Subclavian steal syndrome is not a genetic condition and does not have a carrier status. It is a vascular disorder caused by a significant blockage or stenosis in the subclavian artery, leading to a reversal of blood flow in the vertebral artery to compensate for the reduced blood supply.
Mechanism: Subclavian steal syndrome occurs when there is a stenosis (narrowing) or occlusion (blockage) of the subclavian artery proximal to the origin of the vertebral artery. This condition leads to a reversal of blood flow in the ipsilateral vertebral artery to supply the affected arm, effectively "stealing" blood from the brain.

Mechanism:
1. Stenosis or occlusion of the subclavian artery leads to reduced blood flow downstream.
2. The body compensates by reversing the flow in the vertebral artery, which typically supplies blood to the brain, to serve the higher demand area, such as the ischemic arm.
3. This results in reduced cerebral perfusion, which can cause symptoms related to diminished blood supply to the brain, especially during arm exertion.

Molecular Mechanisms:
The molecular aspects involve:
1. Endothelial dysfunction in the subclavian artery, leading to atherosclerosis.
2. Inflammatory responses with the involvement of molecules like cytokines and adhesion molecules, contributing to plaque formation and vascular stiffening.
3. Smooth muscle cell proliferation and extracellular matrix remodeling, influenced by growth factors such as platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-β), further exacerbating the stenosis.
Treatment: Management for this condition includes:
Carotid subclavian bypass
Stent and balloon angioplasty
Endarterectomy
Compassionate Use Treatment: Subclavian steal syndrome (SSS) is primarily treated through surgical or endovascular methods to restore adequate blood flow. Compassionate use, off-label, or experimental treatments for SSS can include the following:

1. **Endovascular stenting**: While this is a common treatment, certain stents or techniques not specifically approved for SSS might be used off-label.

2. **Percutaneous transluminal angioplasty (PTA)**: This involves the use of balloon angioplasty, sometimes off-label, to widen the affected subclavian artery.

3. **Pharmacological Agents**: While not a standard treatment for SSS itself, medications like antiplatelets or anticoagulants might be used off-label to manage associated symptoms or prevent complications.

These alternative approaches may be considered when conventional therapies are not feasible or have failed, and they should ideally be administered under the guidance of a specialist.
Lifestyle Recommendations: For subclavian steal syndrome, the following lifestyle recommendations can be helpful:

1. **Quit Smoking**: Smoking can worsen atherosclerosis and increase the risk of cardiovascular diseases.
2. **Healthy Diet**: Adopt a diet low in saturated fats, trans fats, cholesterol, and sodium. Focus on eating fruits, vegetables, whole grains, and lean protein.
3. **Regular Exercise**: Engage in moderate aerobic exercise for at least 30 minutes most days of the week to improve cardiovascular health. Consult your physician before starting any new exercise regimen.
4. **Weight Management**: Maintain a healthy body weight to reduce strain on the cardiovascular system.
5. **Monitor Blood Pressure**: Regularly check your blood pressure and manage it through lifestyle changes and, if necessary, medication.
6. **Manage Diabetes**: Keep blood sugar levels under control if you have diabetes.
7. **Limit Alcohol**: Drink alcohol in moderation, if at all.
8. **Regular Medical Checkups**: Keep up with regular medical appointments to monitor your condition and implement preventive measures.

Lifestyle changes should be comprehensive and consistently maintained to effectively manage and potentially improve subclavian steal syndrome.
Medication: Subclavian steal syndrome (SSS) primarily involves the narrowing or blockage of the subclavian artery, leading to blood flow reversal in the vertebral artery. While medication is not typically the primary treatment for SSS, it can be used to manage symptoms or associated conditions. Common medications may include:

1. Antiplatelet agents (e.g., aspirin, clopidogrel) to reduce the risk of clot formation.
2. Statins to lower cholesterol and stabilize plaques in the arteries.
3. Antihypertensive medications to control blood pressure and reduce strain on the arteries.

Treatment often focuses on addressing the underlying artery stenosis, which may require surgical intervention or angioplasty. Always consult a healthcare professional for diagnosis and treatment tailored to individual cases.
Repurposable Drugs: There are no specific drugs repurposed solely for subclavian steal syndrome. Management typically focuses on addressing the underlying cause, such as atherosclerosis, often through lifestyle modifications, antiplatelet therapy, and lipid-lowering agents. In some cases, surgical or interventional procedures like angioplasty or stenting may be recommended. For personalized treatment, a consultation with a healthcare provider is essential.
Metabolites: Subclavian steal syndrome does not typically involve specific metabolites as it is primarily a vascular disorder. It occurs when there is a blockage or significant stenosis in the subclavian artery, leading to a reversal of blood flow in the vertebral artery to compensate for the reduced blood flow to the arm. This condition is not directly associated with the metabolism of specific substances. If you need more detailed information on symptoms, diagnosis, or treatment, please let me know.
Nutraceuticals: For Subclavian Steal Syndrome, there are no specific nutraceuticals recommended as primary treatment. The condition usually requires medical intervention such as angioplasty or stenting to address the vascular obstruction. Lifestyle modifications and management of cardiovascular risk factors (e.g., controlling hypertension, diabetes, and cholesterol) may also be advised. Always consult with a healthcare professional for an appropriate treatment plan.
Peptides: Subclavian steal syndrome (SSS) occurs when there's a blockage or narrowing of the subclavian artery, leading to reversed blood flow in the vertebral artery. This can cause a reduction of blood supply to the brain and arm, resulting in symptoms like dizziness, vertigo, and arm pain with exertion. While peptides are not specifically mentioned in standard treatments or diagnostic processes for SSS, managing the condition typically involves addressing the underlying vascular issues, potentially through lifestyle changes, medication, or surgical interventions such as angioplasty or stenting.